In non-small-cell lung cancer (NSCLC), both FABP3 and FABP4 are upregulated and positively correlated with the advanced tumour node metastasis stage (TNM) across matched cancerous and non-cancerous tissue from 30 patients [35]. Here, FABP3 is linked to non-small cell lung carcinoma.